FTO has been found to play a pivotal role in regulating transcriptome-wide m6A modification of mRNA, and it is one of demethylases that has been associated with metabolic disorders, such as diabetes, obesity, and cardiovascular disease (19, 40, 41). Here, MBD2 is linked to metabolic disease.